Esmolol Use in Dual Axis Defibrillation Resistant Ventricular Fibrillation

Case Reports in Cardiology
Ankit AgrawalChirag Shah

Abstract

Cardiac arrest in an event of acute myocardial infarction most commonly results in life-threatening ventricular tachycardia or ventricular fibrillation (VF). Patients who remain in VF despite optimal epinephrine, amiodarone, and three or more attempts at 200 joules of biphasic current defibrillation are known to be in an electrical storm. Here, we describe a case of defibrillation refractory VF responding to intravenous esmolol resulting in a successful return of spontaneous circulation. Learning objective. This case reinforces the growing body of evidence supporting esmolol as a novel treatment approach for refractory VF before the cessation of resuscitative efforts.

References

Apr 1, 1994·Journal of the American College of Cardiology·D H HochJ H Levine
Dec 15, 2012·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Aug 16, 2016·Resuscitation·Young Hwan LeeSeung Min Park
Nov 12, 2016·The Western Journal of Emergency Medicine·Kevin M BoehmJ Michelle Moccia
May 8, 2018·The American Journal of Emergency Medicine·Karim HajjarGilbert Abou Dagher
Mar 11, 2019·BMJ Case Reports·Charles W HwangTorben K Becker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.